Glory Holdings reported on January 8 that Fulejia (301371.SZ) recently stated in its investor relations activities that the company currently has sodium hyaluronate sub-packaged repair solution and anti-aging tightening sub-packaged essence available for sale. It is expected that this year, we will also launch a new sub-packaged solution with sodium hyaluronate ingredients, classified as a Class II medical instrument.
- Headlines
- Shiyerjia (301371.SZ): It is expected that a new type II medical instrument product containing sodium hyaluronate will be launched this year.
敷尔佳(301371.SZ)：预计今年还会上新一款Ⅱ类医疗器械产品透明质酸钠成份的次抛液
Shiyerjia (301371.SZ): It is expected that a new type II medical instrument product containing sodium hyaluronate will be launched this year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
16:42
Shandong Xinhua Pharmaceutical: The controlled-release Tramadol hydrochloride tablets have passed the generics consistency evaluation.
Shandong Xinhua Pharmaceutical-7.46%
16:37
Next week, the central bank's open market will have 30.9 billion yuan reverse repos and 995 billion yuan MLF maturing.
16:35
Huang Yanming stated: I am currently still working at GTJA and have not changed jobs.
Guotai Junan-0.74%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.